[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$513melevidys Graphic $513melevidys

$513melevidys beats Q2 revenue expectations but faces FDA scrutiny. Investors are watching for further developments and guidance.

About $513melevidys

Analysis of social media posts related to the stock ticker $513melevidys.

Top topics mentioned In the posts about $513melevidys in the last XX hours

$reymi, whatsapp, Sentiment, $282m

Top Social Posts #

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$SRPT holds gains after Q2 revenue hits $513MElevidys beats with $282M though FDA scrutiny on paused dosing tempers sentiment. Full trade breakdown is here with entry points and target prices. Add WhatsApp and reply X to get free coaching advice"
@TammyElissa on X 2025-07-17 08:37:20 UTC 4685 followers, XXX engagements